The bacterial flora of the respiratory tract. Some knowns and unknowns. by Austrian, R.
ROBERT AUSTRIAN*
Department of Research Medicine,
The University of Pennsylvania
School ofMedicine,
Philadelphia, Penna., 19104
THE BACTERIAL FLORA OF THE RESPIRATORY TRACT.
SOME KNOWNS AND UNKNOWNS
The upper respiratory tract of man and terrestrial mammals, composed in
part of the nose, nasopharynx, mouth and oropharynx, harbors an extra-
ordinarily varied bacterial flora. Rosebury, in his book entitled Microorgan-
isms Indigenous to Man' lists no less than 21 genera of bacteria (Table 1)
TABLE 1. GENERA OF BACTERIA INHABITING THE UPPER RESPIRATORY TRACT*
Staphylococcus
Streptococcus
Peptostreptococcus
Diplococcus
Neisseria
Veillonella
Lactobacillus
Corynebacterium
Leptotrichia
Escherichia
Paracolobactrum
Klebsiella
Proteus
Pseudomonas
Moraxella
Mima
Haemophilus
Bacteroides
Fusobacterium
Spirillum
Vibrio
* Modified from Reference 1, pp. 318-321.
that may be isolated from the mucous membranes lining these structures.
Although the lower respiratory tract is in direct continuity with the secre-
tions draining the upper respiratory tract, it is, by contrast, normally
sterile.2` This remarkable difference is brought about by a series of co-
ordinated mechanisms of the mammalian host which act to protect the
tracheobronchial tree and pulmonary parenchyma from infection. Only
when injury, acute or chronic, has occurred does bacterial infection of the
lower respiratory tract usually arise. There are some exceptions to this
generalization such as diptheria and perhaps pertussis, pneumonic plague
and tularemia, and tuberculosis; but in general, this view seems valid.
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There is little if any evidence that bacterial infection of the lower respira-
tory tract plays a significant primary role in the development of chronic
obstructive bronchitis or of pulmonary emphysema. It would appear rather
that, once structural or physiological changes or both have occurred in the
structures of the lower respiratory tract, both saprophytic and pathogenic
bacteria may obtain a foothold that would have been denied them in normal
subjects. Having done so, they may bring about further impairment of
ventilatory and respiratory functions and threaten both the well-being and
life of the patient. It would not be possible in the time allotted to consider
the entire bacterial flora of the respiratory tract. Instead, an attempt will
be made to highlight some of the areas of our ignorance, which are legion,
and to indicate certain lines of approach that may be useful in future studies.
By so doing, others may be moved to explore further some of the bac-
teriologic problems of respiratory infection which are sorely in need of
solution. Among these are the means whereby pathogenic bacteria injure
the respiratory tract, the classification and potentially pathogenic role of
those bacterial species often looked upon as saprophytes or as opportunist
pathogens, and the discovery of more suitable experimental hosts in which
to study the behavior of these organisms.
Of the bacteria isolated from the sputum and from tracheobronchial
secretions of patients with chronic obstructive airway disease, most atten-
tion has been focused upon Diplococcus pneurnoniae, Haemophilus influ-
enzae, coagulase-positive Staphylococcus aureus, Streptococcus pyogenes
and the enterobacteriaceae. Although alpha and nonhemolytic streptococci.
neisseriae and coagulase-negative staphylocci have often been found associ-
ated with the aforementioned organisms in specimens obtained directly
from the lower respiratory tract,3" little emphasis has been placed upon
their potential role as infectious agents because of their recognized limited
capacity to invade the tissues of normal individuals. Whether or not such
an attitude is justifiable is perhaps open to question. In considering the
flora of the respiratory tract, I should like to comment briefly upon our
observations on some of the species indigenous to it and to indicate addi-
tional areas in which further studies are needed.
Pneuntococcal infectioni
Although pneumococcal infection is no longer regarded by many to be
as prevalent or as serious as it was two decades ago, available evidence
suggests that it occurs as frequently as it did in the era antedating the
availability of antimicrobial drugs. Investigations by the author of the in-
cidence of primary pneumococcal pneumonia in several American cities in
the past 15 years indicate that 40 to 50 bacteremic infections with this or-
401
Bacterial floraYALE JOURNAL OF BIOLOGY AND MEDICINE Volume 40, April, June, 1968
ganism will be observed per annum for every 200 to 250 ward beds on a
city hospital medical service. Many of those so afflicted are individuals with
underlying systemic illness, including disease of the respiratory tract. In
addition to giving rise to pneumonia, pneumococcus appears to be an im-
portant cause of intercurrent purulent bronchitis in patients with chronic
obstructive airway disease.' In this latter role, it shares an importance com-
parable to that of Haemophilus influenzae. When sought with the aid of
well-established bacteriologic techniques, it is commonly present in the
respiratory secretions of patients with respiratory disease. From 2,485
cultures of the respiratory tract examined between July 1, 1966 and June
30, 1967, 371 strains of pneumococcus were isolated. This figure is a crude
one, not having been adjusted for patients receiving antimicrobial drugs
inhibitory to pneumococcus before or after admission to the hospital. The
distribution of pneumococcal types isolated is similar, with few exceptions,
to that observed prior to the advent of antibiotics. The virtual absence of
pneumococcus Type II from the Eastern United States for the past two
decades has been noteworthy.
Even though it is still an important respiratory pathogen, almost noth-
ing is known about the means whereby pneumococcus brings about tissue
injury and death. Solution of this problem may be of considerable im-
portance in reducing both the morbidity and mortality resulting from
pneumococcal infection. Of potential value, in the meantime, to persons of
high risk of injury from pneumococcal infections is polyvalent pneumococcal
vaccine.6 It is hoped that such vaccine may become available again in the
not too distant future.
Streptococci in the respiratory tract
The alpha and nonhemolytic streptococci are almost universal inhabitants
of the upper respiratory tract. Though they share a number of properties
in common with pneumococcus, they are regarded by many as playing a
negligible role in chronic bronchial disease. This view is based in part upon
the observations that elimination of these organisms from respiratory se-
cretions may not be followed by diminution of the purulence of the sputum
of bronchitics with infection and that relapse following antimicrobial therapy
may not occur promptly after the reappearance of such streptococci in the
sputum.' Although these arguments may have some validity, the alpha and
nonhemolytic respiratory streptococci are so commonly present in infected
respiratory secretions and resemble pneumococci in such a variety of at-
tributes that we have thought it worthwhile to attempt to learn more about
this heterogeneous and poorly classified group of organisms.
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Like pneumococcus, most of the alpha and nonhemolytic streptococci of
the respiratory tract are capsulated, a fact that has been overlooked fre-
quently in attempts to classify these organisms serologically in the past.
Awareness of this fact has been heightened by the availability of a serologic
reagent designated "omni-serum" which reacts with all 82 of the capsular
serotypes of pneumococcus.8 In the examination of sputum spreads for the
presence of pneumococci with this reagent, it has been observed not infre-
quently that organisms in chains resembling streptococci give a small but
definitely positive quellung or capsular precipitin reaction. As early as
1925, the production of capsular antigens by streptococci was noted by
Lancefield9 and, in 1941, Morch1' described the occurrence of a capsular
cross-reaction between a streptococcus and pneumococcus. These facts
have led to a systematic study of the capsular antigens of alpha and non-
hemolytic streptococci with the following results.
From 196 cultures of the respiratory tract containing colonies of strepto-
cocci, 98 or 50 per cent included capsulated organisms cross-reacting with
pneumococcus (Table 2). Twenty cultures yielded two strains of strepto-
coccus each cross-reacting with a different pneumococcal serotype, and three
cultures contained three serologically distinct cross-reacting strains of
streptococci. To date, cross-reactions between alpha and nonhemolytic
streptococci and 22 capsular serotypes of pneumococci have been identified
(Table 3). Among these cross-reactions are several between streptococci
classified in Lancefield's groups F and K. Group F streptococcus Type II
cross-reacts with pneumococcus Type 21 and Type 7 or 51, Type III
(Streptococcus MG) with pneumococcus Type 13, and Type V with pneu-
mococcus Type 17. Cross-reactions of streptococci in Group K include
strains giving capsular precipitin reactions with antisera to pneumococci of
Types 36 and 47. It is noteworthy that antisera for the grouping of strepto-
cocci in Lancefield's groups F and K are prepared both in this country and
in Great Britain with streptococci endowed with sufficient capsular poly-
TABLE 2. STREPTOCOCCI CROSS-REACTING WITH PNEUMOCOCCI IN CULTURES
OF THE HUMAN RESPIRATORY TRACT
Total Total Number of cross-reacting
Source cultures positive types per culture
1 2 3
Sputum 172 80 (46%) 61 16 3
N. P. 24 18 14 4 0
Total 196 98 75 20 3
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TABLE 3. ALPHA AND NONHEMOLYTIC STREPTOCOCCI FROM THE HUMAN
RESPIRATORY TRACT CROSS-REACTING WITH PNEUMOCOCCI
Pneumococcal Streptococci Pneumococcal Streptococci
type (No. of strains) type (No. of strains)
5 1 36 10
9 7 39 3
13 11 43 1
8(MG) 47 1
15 6 52-75 3
20 3 59 98
21 10 69 1
24 1 72 18
27 1 75 12
32 1 80 1
33 5 82 1
34 1
saccharide to stimulate formation of anticapsular antibodies. These antisera
are not specific for the cell wall polysaccharides of their respective strepto-
coccal groups and yield positive precipitin and quellung reactions with
organisms possessing related capsular polysaccharides, a situation that
may lead to errors in streptococcal classification.
Because of the evidence that many alpha and nonhemolytic respiratory
streptococci produce capsular polysaccharide, antisera have been prepared
with a number of strains of filamentous streptococci that do not cross-react
with pneumococcus and that have been isolated from the respiratory tract.
To date, 14 serotypes have been identified and given provisional type
designations 83 through 96 to avoid ambiguity vis a vis pneumococcal
capsular serotypes. The frequency of these strains is shown in Table 4.
Serologic cross-reactions between pneumococcus and alpha and non-
hemolytic streptococci are not limited to those between capsular antigens.
Cross-reactions between the cell wall polysaccharides of these two groups
of organisms have been noted also. Highly potent antisera to the C poly-
saccharide of pneumococcus can be prepared with mutants of this organism
producing a capsule of material very similar to, though not identical with
the cell wall polysaccharide of this organism. Hot acid extracts of a variety
of alpha and nonhemolytic streptococci give positive precipitin reactions
with these antisera but fail to do so when the antiserum has been absorbed
with pneumoccocal C polysaccharide (Table 5). Among the organisms
showing this reaction are all five serotypes of streptococci in Lancefield's
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TABLE 4. PROVISIONAL SEROTYPES OF ALPHA AND NONHEMOLYTIC STREPTOCOCCI
FROM THE HUMAN RESPIRATORY TRACT
Provisional type
83
84
85
86
87
88
89
90
91
92
93
94
95
96
Untypable
Number of strains
62
1
2
5
1
1
1
3
1
1
11
1
1
2
97
189
Group F, but some organisms possessing the same or closely related cap-
sular antigens but lacking Group F cell wall polysachharide do not react
with antiserum to pneumococcal C polysaccharide.
In addition to these similarities of alpha and nonhemolytic streptococci
to pneumococcus, others exist. Streptococci are known which, like pneu-
mococcus, are sensitive to optochin and ferment inulin. The most striking
evidence of similarity of some streptococci to pneumococcus, however, lies
in the realm of genetics. Studies of the base ratios of the deoxyribonucleates
of several strains of streptococci have shown them to be similar to those
of pneumococcus.' More significant, however, is the fact that heritable
characters, such as drug resistance, can be transferred from streptococci
to pneumococcus or from pneumococcus to streptococci by means of trans-
formation reactions.1" With the use of the transforming system, it has been
possible to transform pneumococci to a variety of streptococcal capsular
serotypes (Table 6), reactions involving transfer of multigenic pathways.
Such transformation has been possible not only with DNA from streptococ-
cal serotypes cross-reacting with pneumococcal capsular and somatic poly-
saccharides but also with DNA from strains having no demonstrable
serologic relation to pneumococcus. The latter transformed pneumococci
405
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TABLE 5. CROSS-REACTIONS OF LANCEFLD EXTRACTS OF ALPHA
AND NONHEMOLYTIC STREPTOCOCCI WITH ANTISERUM
TO PNEUMOCOCCAL C POLYSACCHARIDE
Streptococcus cross-reacting
wath pneumococcus type:
21
33
36
59
72
75
Provisionally classified
streptococcus type:
83
84
85
86
87
88
89
90
91
92
93
94
95
96
Positive/No. tested
5/9
1/1
2/15
11/36
8/20
7/9
6/32
1/1
1/2
2/5
0/1
1/1
1/1
1/1
1/1
1/1
4/4
1/1
1/1
1/1
produce capsular polysaccharides unrelated to any of the known pneumococ-
cal capsular serotypes.
These many similarities of pneumococci and alpha and nonhemolytic
streptococci raise the question of whether or not the latter should be re-
garded as being of little importance in certain types of respiratory disease.
It should be borne in mind that many capsular types of pneumococcus have
a very low invasive potential both for man and for experimental animals.
Only 3 per cent of all the pneumococcal bacteremias of man are caused by
capsular types 34 through 821' inclusive and mice will survive intraperitoneal
infections with 107 organisms of a number of types."' In this respect, some
strains of pneumococcus are comparable in virulence to a number of alpha
and nonhemolytic streptococci. Under natural and experimental conditions,
both the composition and quantity of capsular polysaccharide produced by
an organism appear to determine in part its invasive properties, and the
latter can be changed through genetic manipulation of the capsule without
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TABLE 6. CAPSULAR TRANSFORMATIONS OF PNEUMOCOCCUS
WITH STREPTOCOCCAL DNA
Source ofDNA: Capsular type of
Str. cross-reacting transformed pneum.
zvith pneum. type
9 9and III-9*
13 13
20 20
47 47
59 59
72 72
75 75
Str. provisional
type
85 85
86 86
* Binary capsular phenotype producing Type III pneumococcal capsular polysac-
charide and streptococcal capsular polysaccharide cross-reacting with pneumococcus
Type IX.
obvious alteration of the soma. In addition, it has been shown by Rich and
McKee'5 that noncapsulated pneumococci produce lesions in agranulocytic
rabbits closely akin to those produced by capsulated strains in normal and
agranulocytic rabbits. The means whereby pneumococci bring about the
injury and death of an infected subject is still unknown. It is not outside
the realm of probability that, given an equal foothold, some strains of alpha
and nonhemolytic streptococci may produce injury in a fashion similar to
pneumococcus. The question cannot be resolved until more is learned about
the pathogenic properties of both groups of organisms. Similarities already
demonstrated are such, however, as to make additional studies of the alpha
and nonhemolytic streptococci of the respiratory tract worthwhile. Of
great interest would be examination of those strains isolated during properly
executed bronchoscopy or from secretions obtained by sublaryngeal tracheal
puncture and aspiration. There is a need also for a suitable animal model
in which to study the behavior of these organisms.
The beta hemolytic streptococci appear to play a numerically less im-
portant role in the infection of patients with chronic bronchial disease than
do other recognized bacterial pathogens of the respiratory tract. The beta
hemolytic streptococci of Lancefield's Group A have been described so ex-
tensively elsewhere that they will not be considered here.
Staphylococci comprise another group of organisms which are apparently
significant in causing infection of the tracheobronchial tree. Hemolytic,
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coagulase-producing, pigmented strains are recognized to be virulent where-
as their nonpigmented, noncoagulase-producing counterparts are thought
to be of lesser importance. Much remains to be learned about both groups
of organisms with regard to the mechanisms whereby they produce disease
and especially with regard to the role of the immunologic responses of the
host as a means of limiting infection by them.
Haentophiluts influenzae
Of the organisms associated with infection of patients with chronic ob-
structive bronchial disease, none has been stressed more strongly in the
past decade, especially in Great Britain, than Haemophilus influenzae. This
bacillus is a frequent inhabitant of the upper respiratory tract, though one
that is easy to overlook unless appropriate cultural techniques are employed.
A recent compilation of surveys for its presence in normal subjects indicates
carrier rates between 25 per cent and 84 per cent in groups of individuals
examined on one occasion. These surveys include both capsulated and non-
capsulated variants of which the former constitute only 5 to 6 per cent.'
Relatively few data are available on the isolation of the six capsulated types
of Haemophilus influenzae, though the more recent availability of capsular
typing sera from commercial sources has resulted in augmentation of
earlier information. Table 7 represents a compilation of the type distribution
of capsulated H. influenzae recovered from the respiratory tract, taken
from several sources,1818 and includes strains from both normal subjects and
those with respiratory disease. Types b, e, and f appear to be those most
commonly isolated. Longitudinal study of a group of chronic bronchitics
has resulted in the isolation of four different capsular types of H. influenzae
from a single patient though more than one capsular type was never re-
TABLE 7. DISTRIBUTION OF CAPSULAR TYPES OF HAEMOPHILUS INFLUENZAE
ISOLATED FROM THE RESPIRATORY TRACT*
Type Number Per cent
a 38 8.4
b 234 51.5
c 13 2.9
d 16 3.5
e 78 17.2
f 75 16.5
Total 454 100
* Combined data. See rfs. no. 16, 17 and 18.
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covered from a single culture."8 Of the 599 cultures typed by slide ag-
glutination in this study, 26 per cent were capsulated, a considerably higher
proportion than that noted by most investigators.
Insofar as classification is concerned, noncapsulated strains of H. in-
fluenzae have posed a much more difficult problem than their capsulated
counterparts. Agglutination of such strains by appropriately prepared
antisera suggests a wide degree of antigenic heterogeneity. More recent
studies of extracts of organisms solubilized by a variety of techniques have
demonstrated the presence of several species-specific antigens, some pos-
sibly polysaccharide in nature.19' There is currently a need, however, for
a more thorough biochemical investigation of the structural components of
H. influenzae with modern techniques to shed light on the antigenic elements
of this organism. Wider use of the quellung or capsular precipitin reaction
in the study of H. influenzae might also be worthwhile, for organisms fail-
ing to produce irridescent colonies on suitable media are usually regarded
as lacking capsular antigens by this somewhat insensitive technique.
Another area of investigation that has not been exploited and that might
prove fruitful is genetic study of the noncapsulated strains of H. influenzae
isolated from the respiratory tract. Like pneumococcus, H. influenzae is
readily susceptible to genetic transformation.' Transfer of the genes con-
trolling capsulation and drug resistance from suitable donor strains to
noncapsulated strains isolated from the respiratory tract might shed addi-
tional light on their relatedness to capsulated variants.
From studies of sputum and of respiratory secretions obtained directly
from the lower respiratory tract, it is evident that both capsulated and
noncapsulated organisms may be present in patients with chronic obstruc-
tive airway disease during clinical episodes of infection. The potentially
hurtful role of noncapsulated variants of H. influenzae has been inferred
both from their demonstrated presence in the bronchial tissues' of patients
with chronic bronchial disease and from the improvement of patients con-
comitant with the elimination of the organism from the respiratory tract
following antimicrobial therapy. More will need to be learned about the
biology of this fastidious organism, however, before its pathogenic role
can be understood fully. Like pneumococcus, it may produce neuramini-
dases," although the role of these bacterial enzymes in respiratory disease
remains to be elucidated. In addition, it may be necessary to explore further
its behavior in subhuman primates to obtain a suitable animal host in which
more satisfactory, controlled pathologic study of its behavior in the respira-
tory tract can be accomplished.
The enterobacteriaceae comprise another group of organisms with the
capacity to injure the lower respiratory tract. Unlike the bacteria just
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considered, these organisms reside more commonly in the gastrointestinal
tract and are a frequent cause of abdominal and genitourinary tract in-
fection. They are found at times, however, in the normal mouth and
pharynx' and are not infrequent inhabitants of the upper respiratory tract
when the normal flora of gram-positive bacteria has been suppressed by
selective antimicrobial drugs. They have been isolated from the bronchial
secretions of patients with chronic bronchial disease under conditions which
exclude contamination by organisms in the upper respiratory tract and
are the cause of perhaps 5 per cent of the bacterial pneumonias seen in
hospitals. A recent study of 82 pneumonias caused by enterobacteria sug-
gests that more than half of such infections are attributable to organisms in
the Klebsiella-Enterobacter group and to E. coli."
Klebsiella pneumoniae
Klebsiella pneumoniae has long been associated with infection of the
respiratory tract, as its name implies. Like pneumococcus and a number of
other inhabitants of the respiratory tract, it is found usually to be cap-
sulated when isolated from man. More than 70 different capsular serotypes
of Klebsiella pneumoniae are now known; but as has been the case with H.
influenzae, because of the unavailability of typing sera, very few data have
been collected regarding the role of different serotypes of K. pneumoniae
in disease of the human respiratory tract. In the earlier studies of Edwards
and Fife" and of 0)rskov,'7 a total of 292 strains from respiratory secre-
tions were typed. To add to these data, the collaboration of Dr. William H.
Ewing, Chief, Enteric Bacteriology Unit, Bacteriology Section of the Com-
municable Disease Center, Atlanta, Georgia was obtained. Through his
cooperation, an additional 186 strains of K. pneunoniae isolated from
human respiratory secretions have been typed. These strains were all re-
covered from patients hospitalized on the medical service of the Phila-
delphia General Hospital with suspected respiratory disease between
February, 1966 and July, 1967. The data have not yet been analyzed to
determine the role of klebsiellas in the illnesses of the patients from whom
they were isolated. The relative frequency of the isolation of klebsiellas
with respect to pneumococci, however, is not without interest. Between
July 1, 1966 and June 30, 1967, 2,485 cultures of respiratory secretions
were examined. From these cultures, 371 strains of pneumococcus and 198
strains of K. pneumoniae were isolated. These figures have not been ana-
lyzed for the selective effect of antimicrobial therapy prior to or during
hospitalization. They are indicative, however, that K. pneumoniae is a com-
mon inhabitant of the respiratory tract of hospitalized patients. Fifty-three
capsular serotypes were represented among the strains isolated, 10 of which
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TABLE 8. TYPE DISTRIBUTION OF KLYSIELLA PNEUMONIAE ISOLATED FROM
THE HUMAN RESPIRATORY TRACT*
Type No. of strains Type No. of strains
2 53 25 12
1 47 19 11
4 39 5 10
3 16 17 10
8 14 7 9
35 14 27 9
9 13 41 9
18 12 Other 198
Total -476
* Combined data. See rfs. no. 25, 26, 27.
had not been included in the earlier studies of Edwards and Fife and of
0rskov. The limited data on the distribution of klebsiella types are shown
in Table 8. Fourteen types account for 62 per cent of the isolates from
respiratory secretions, and Types 1, 2 and 4 for 34 per cent. There is
reason to believe that typing sera for klebsiellas may be available com-
mercially in the not too distant future. If so, it will be possible to accumulate
considerably more information about this respiratory pathogen than has
been possible in the past. With regard to E. coli, there is a similar lack of
information about serotypes responsible for respiratory infection. Here
again, information is needed.
The foregoing fragmentary data have been presented to illustrate some-
thing of what is known about some of the bacterial inhabitants of the respira-
tory tract that play a role in chronic bronchial infection and to indicate
certain of the approaches that can be employed to learn more about them.
No mention has been made of many of the genera listed in Table 1, some
of which, including the destructive anaerobes, may play an important role
in bronchial disease and require further study. At our present point in
time it is obvious that we need to know a great deal more about the biol-
ogy of the bacteria that inhabit the human respiratory tract and the means
whereby they produce tissue injury. To solve these important problems,
much additional study of bacteria isolated directly from the lower respira-
tory tract with the aid of biochemical, immunologic, genetic and epi-
demiologic techniques will be required. Of comparable importance, if an
understanding of pathogenetic mechanisms is to be achieved, will be the
development of suitable animal models in which the behavior of bacteria
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in the respiratory tract can be studied. To gain this latter end, it will prob-
ably be necessary to turn to primate hosts. The increasing availability of
such hosts in the National Primate Centers holds promise that some of
today's difficult problems can be subjected to more meaningful study in the
not too distant future.
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